688366.SH announced that Shanghai Likangrui Biological Engineering Co., Ltd. ("Likangrui"), a wholly owned subsidiary of the company, plans to increase its registered capital by 75 million yuan at the price of 2 yuan per share. Shanghai Shunan Yuan Biotechnology Partnership (Limited Partnership) ("Shun an Yuan") (still under establishment) and Shanghai Kangdingchen Biotech Partnership (Limited Partnership) ("Kang Dingchen") as two employee shareholding platforms, it is proposed to subscribe for Likangrui registered capital of RMB 35 million yuan and RMB 40 million yuan at RMB 70 million and RMB 80 million respectively, with a total capital increase of RMB 150 million. After the completion of the transaction, Haohaisheng Technology holds 70% equity of Likang Rui, while Shunan Yuan and Kang Dingchen hold 14% and 16% equity respectively. Likang Rui's registered capital increased from 175 million yuan to 250 million yuan. Likangrui has changed from a wholly-owned subsidiary of the company to a holding subsidiary of the company, and the scope of the consolidated statement has not changed.